8th Dec 2021

CE-IVD certification for Point-of-Care Genedrive® COV19-ID kit

genedrive plc (LSE: GDR), the near patient molecular diagnostics company, announces that furthe...

29th Nov 2021

Point of Care Genedrive® COV19-ID submitted for CE-IVD certification

genedrive plc (LSE: GDR), the near patient molecular diagnostics company, announces that it has...

29th Sep 2021

New Genedrive® System receives CE-IVD marking device ready for Antibiotic Induced Hearing Loss launch

genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces that the ne...